Paper11368258
Effect of metronidazole on the growth of vaginal lactobacilli in vitro.
Simoes JA and 3 others. Infect Dis Obstet Gynecol, 2001. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Papers, record 11368258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11368258
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Lactobacillus | Major topic |
| Metronidazole | Major topic |
| Vagina | Major topic |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Statistics, Nonparametric |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6465238 | Analysis of metronidazole penetration into vaginal fluid by reversed-phase high-performance liquid chromatography. | Am J Obstet Gynecol | 1984 | https://conductscience.org/library/papers/6465238 | PubMed |
| 2 | 10908773 | Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. | Obstet Gynecol | 2000 | https://conductscience.org/library/papers/10908773 | PubMed |
| 3 | 727761 | Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/727761 | PubMed |
| 4 | 10100770 | Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. | Sex Transm Dis | 1999 | https://conductscience.org/library/papers/10100770 | PubMed |
| 5 | 8141197 | Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. | Am J Obstet Gynecol | 1994 | https://conductscience.org/library/papers/8141197 | PubMed |
| 6 | 8497364 | Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. | Obstet Gynecol | 1993 | https://conductscience.org/library/papers/8497364 | PubMed |
| 7 | 17035761 | Bacterial vaginosis: sequelae and management. | Curr Opin Infect Dis | 1999 | https://conductscience.org/library/papers/17035761 | PubMed |
| 8 | 8440952 | Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8440952 | PubMed |
| 9 | 7876396 | Pharmacokinetics of intravaginal metronidazole gel. | J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7876396 | PubMed |
| 10 | 7502179 | The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. | Sex Transm Dis | 1995 | https://conductscience.org/library/papers/7502179 | PubMed |
| 11 | 708015 | Inactivation of metronidazole by anaerobic and aerobic bacteria. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/708015 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42551328 | 3D cell assemblies for controlled evaluation of response to dual agent delivery nanofibers targeting bacterial vaginosis. | Biomater Adv | 2026 | https://conductscience.org/library/papers/42551328 | PubMed |
| 42190999 | Electrospun nanofibers for antibiotic and probiotic co-delivery to target bacterial vaginosis. | Int J Pharm | 2026 | https://conductscience.org/library/papers/42190999 | PubMed |
| 41740442 | The effects of drinking water with essential oils-organic acids blend replacing preventive antibiotics during withdrawal period on growth performance and gut health of broilers in a commercial farm. | Poult Sci | 2026 | https://conductscience.org/library/papers/41740442 | PubMed |
| 40612718 | Anti-candida activity of Lacticaseibacillus rhamnosus R-2002 and its possible application in candidiasis prevention. | Iran J Microbiol | 2025 | https://conductscience.org/library/papers/40612718 | PubMed |
| 40529156 | Dual probiotic and antibiotic therapy targeting bacterial vaginosis: an integrated experimental/computational modeling perspective. | Biomed Eng Adv | 2025 | https://conductscience.org/library/papers/40529156 | PubMed |
| 38854974 | The phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus with potential probiotic properties isolated from healthy women in northern Iran. | Iran J Microbiol | 2024 | https://conductscience.org/library/papers/38854974 | PubMed |
| 37627701 | Antibiotic Resistance and Probiotics: Knowledge Gaps, Market Overview and Preliminary Screening. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37627701 | PubMed |
| 35685517 | Effects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review. | Int J Clin Pract | 2022 | https://conductscience.org/library/papers/35685517 | PubMed |
| 35464937 | Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35464937 | PubMed |
| 35082535 | Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study. | Int J Womens Health | 2022 | https://conductscience.org/library/papers/35082535 | PubMed |
| 34948426 | Engineering of Vaginal Lactobacilli to Express Fluorescent Proteins Enables the Analysis of Their Mixture in Nanofibers. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948426 | PubMed |
| 34925343 | Tilapia Piscidin 4 (TP4) Reprograms M1 Macrophages to M2 Phenotypes in Cell Models of Gardnerella vaginalis-Induced Vaginosis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34925343 | PubMed |
| 33262350 | Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis. | Nat Commun | 2020 | https://conductscience.org/library/papers/33262350 | PubMed |
| 32497109 | Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/32497109 | PubMed |
| 26137971 | Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/26137971 | PubMed |
| 24900434 | Potentiating Metronidazole Scaffold against Resistant Trichomonas: Design, Synthesis, Biology and 3D-QSAR Analysis. | ACS Med Chem Lett | 2012 | https://conductscience.org/library/papers/24900434 | PubMed |
| 24566190 | Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24566190 | PubMed |
| 22219582 | Bacterial vaginosis: Etiology and modalities of treatment-A brief note. | J Pharm Bioallied Sci | 2011 | https://conductscience.org/library/papers/22219582 | PubMed |
| 20657710 | NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW. | Int J Probiotics Prebiotics | 2008 | https://conductscience.org/library/papers/20657710 | PubMed |
| 17485797 | Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. | Infect Dis Obstet Gynecol | 2006 | https://conductscience.org/library/papers/17485797 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11368258
GET https://conductscience.org/api/papers/v1/11368258/cited_by?page=2